French medical technology company EDAP secures €36 million credit facility from EIB to advance prostate cancer and endometriosis non-invasive treatment - The European Sting
French medical technology company EDAP secures €36 million credit facility from EIB to advance prostate cancer and endometriosis non-invasive treatment The European Sting
Honokiol inhibits cell migration and invasion by blocking EMT via Snail/Slug axis in endometriosis.
Endometriosis, a common gynecological disease, leads to dysmenorrhea and infertility. EMT process was closely related to the pathology of endometriosis. More therapies were required to be explored for endometriosis management. …